|
1
|
McLean K, VanDeVen NA, Sorenson DR, Daudi
S and Liu JR: The HIV protease inhibitor saquinavir induces
endoplasmic reticulum stress, autophagy, and apoptosis in ovarian
cancer cells. Gynecol Oncol. 112:623–630. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Lee RX, Li QQ and Reed E: β-elemene
effectively suppresses the growth and survival of both
platinum-sensitive and -resistant ovarian tumor cells. Anticancer
Res. 32:3103–3113. 2012.PubMed/NCBI
|
|
3
|
Yang YI, Kim JH, Lee KT and Choi JH:
Costunolide induces apoptosis in platinum-resistant human ovarian
cancer cells by generating reactive oxygen species. Gynecol Oncol.
123:588–596. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wahl H, Tan L, Griffith K, Choi M and Liu
JR: Curcumin enhances Apo2L/TRAIL-induced apoptosis in
chemoresistant ovarian cancer cells. Gynecol Oncol. 105:104–112.
2007. View Article : Google Scholar
|
|
5
|
Buolamwini JK: Cell cycle molecular
targets in novel anticancer drug discovery. Curr Pharm Des.
6:379–392. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Diaz-Moralli S, Tarrado-Castellarnau M,
Miranda A and Cascante M: Targeting cell cycle regulation in cancer
therapy. Pharmacol Ther. 138:255–271. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Luo H, Rankin GO, Li Z, Depriest L and
Chen YC: Kaempferol induces apoptosis in ovarian cancer cells
through activating p53 in the intrinsic pathway. Food Chem.
128:513–519. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Sarkar A and Bhaduri A: Black tea is a
powerful chemopreventor of reactive oxygen and nitrogen species:
Comparison with its individual catechin constituents and green tea.
Biochem Biophys Res Commun. 284:173–178. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Koňariková K, Ježovičová M, Keresteš J,
Gbelcová H, Ďuračková Z and Žitňanová I: Anticancer effect of black
tea extract in human cancer cell lines. Springerplus. 4:1272015.
View Article : Google Scholar
|
|
10
|
Qian Y, Zhu K, Wang Q, Li G and Zhao X:
Antimutagenic activity and preventive effect of black tea on buccal
mucosa cancer. Oncol Lett. 6:595–599. 2013.PubMed/NCBI
|
|
11
|
Cassidy A, Huang T, Rice MS, Rimm EB and
Tworoger SS: Intake of dietary flavonoids and risk of epithelial
ovarian cancer. Am J Clin Nutr. 100:1344–1351. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Jin D, Xu Y, Mei X, Meng Q, Gao Y, Li B
and Tu Y: Antiobesity and lipid lowering effects of theaflavins on
high-fat diet induced obese rats. J Funct Foods. 5:1142–1150. 2013.
View Article : Google Scholar
|
|
13
|
Li B, Vik SB and Tu Y: Theaflavins inhibit
the ATP synthase and the respiratory chain without increasing
superoxide production. J Nutr Biochem. 23:953–960. 2012. View Article : Google Scholar
|
|
14
|
Bhattacharya U, Halder B, Mukhopadhyay S
and Giri AK: Role of oxidation-triggered activation of JNK and p38
MAPK in black tea polyphenols induced apoptotic death of A375
cells. Cancer Sci. 100:1971–1978. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Adhikary A, Mohanty S, Lahiry L, Hossain
DM, Chakraborty S and Das T: Theaflavins retard human breast cancer
cell migration by inhibiting NF-kappaB via p53-ROS cross-talk. FEBS
Lett. 584:7–14. 2010. View Article : Google Scholar
|
|
16
|
Schuck AG, Ausubel MB, Zuckerbraun HL and
Babich H: Theaflavin-3,3′-digallate, a component of black tea: An
inducer of oxidative stress and apoptosis. Toxicol In Vitro.
22:598–609. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhang G, Miura Y and Yagasaki K:
Suppression of adhesion and invasion of hepatoma cells in culture
by tea compounds through antioxidative activity. Cancer Lett.
159:169–173. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Sullivan KD, Gallant-Behm CL, Henry RE,
Fraikin JL and Espinosa JM: The p53 circuit board. Biochim Biophys
Acta. 1825.229–244. 2012.
|
|
19
|
Levine AJ, Hu W and Feng Z: The P53
pathway: What questions remain to be explored? Cell Death Differ.
13:1027–1036. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kao CL, Hsu HS, Chen HW and Cheng TH:
Rapamycin increases the p53/MDM2 protein ratio and p53-dependent
apoptosis by translational inhibition of mdm2 in cancer cells.
Cancer Lett. 286:250–259. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Abedini MR, Muller EJ, Bergeron R, Gray DA
and Tsang BK: Akt promotes chemoresistance in human ovarian cancer
cells by modulating cisplatin-induced, p53-dependent ubiquitination
of FLICE-like inhibitory protein. Oncogene. 29:11–25. 2010.
View Article : Google Scholar
|
|
22
|
Miura K, Satoh M, Kinouchi M, Yamamoto K,
Hasegawa Y, Kakugawa Y, Kawai M, Uchimi K, Aizawa H, Ohnuma S, et
al: The use of natural products in colorectal cancer drug
discovery. Expert Opin Drug Discov. 10:411–426. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Chen H, Landen CN, Li Y, Alvarez RD and
Tollefsbol TO: Epigallocatechin gallate and sulforaphane
combination treatment induce apoptosis in paclitaxel-resistant
ovarian cancer cells through hTERT and Bcl-2 down-regulation. Exp
Cell Res. 319:697–706. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yang Z, Jie G, Dong F, Xu Y, Watanabe N
and Tu Y: Radical-scavenging abilities and antioxidant properties
of theaflavins and their gallate esters in
H2O2-mediated oxidative damage system in the
HPF-1 cells. Toxicol In Vitro. 22:1250–1256. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Li B, Gao Y, Rankin GO, Rojanasakul Y,
Cutler SJ, Tu Y and Chen YC: Chaetoglobosin K induces apoptosis and
G2 cell cycle arrest through p53-dependent pathway in
cisplatin-resistant ovarian cancer cells. Cancer Lett. 356(2 Pt B):
418–433. 2015. View Article : Google Scholar :
|
|
26
|
Hu W, Wang F, Tang J, Liu X, Yuan Z, Nie C
and Wei Y: Proapoptotic protein Smac mediates apoptosis in
cisplatin-resistant ovarian cancer cells when treated with the
anti-tumor agent AT101. J Biol Chem. 287:68–80. 2012. View Article : Google Scholar :
|
|
27
|
Wilson TR, Johnston PG and Longley DB:
Anti-apoptotic mechanisms of drug resistance in cancer. Curr Cancer
Drug Targets. 9:307–319. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Brunelle JK and Letai A: Control of
mitochondrial apoptosis by the Bcl-2 family. J Cell Sci.
122:437–441. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kim SY, Lee DH, Song X, Bartlett DL, Kwon
YT and Lee YJ: Role of Bcl-xL/Beclin-1 in synergistic apoptotic
effects of secretory TRAIL-armed adenovirus in combination with
mitomycin C and hyperthermia on colon cancer cells. Apoptosis.
19:1603–1615. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Liu T, Hannafon B, Gill L, Kelly W and
Benbrook D: Flex-Hets differentially induce apoptosis in cancer
over normal cells by directly targeting mitochondria. Mol Cancer
Ther. 6:1814–1822. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ozören N and El-Deiry WS: Cell surface
death receptor signaling in normal and cancer cells. Semin Cancer
Biol. 13:135–147. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Lahiry L, Saha B, Chakraborty J, Adhikary
A, Mohanty S, Hossain DM, Banerjee S, Das K, Sa G and Das T:
Theaflavins target Fas/caspase-8 and Akt/pBad pathways to induce
apoptosis in p53-mutated human breast cancer cells. Carcinogenesis.
31:259–268. 2010. View Article : Google Scholar
|
|
33
|
Saha P, Banerjee S, Ganguly C, Manna S,
Panda CK and Das S: Black tea extract can modulate protein
expression of H-ras, c-Myc, p53, and Bcl-2 genes during pulmonary
hyperplasia, dysplasia, and carcinoma in situ. J Environ Pathol
Toxicol Oncol. 24:211–224. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Kawabe T: G2 checkpoint abrogators as
anticancer drugs. Mol Cancer Ther. 3:513–519. 2004.PubMed/NCBI
|
|
35
|
Duiker EW, Meijer A, van der Bilt AR,
Meersma GJ, Kooi N, van der Zee AG, de Vries EG and de Jong S:
Drug-induced caspase 8 upregulation sensitises cisplatin-resistant
ovarian carcinoma cells to rhTRAIL-induced apoptosis. Br J Cancer.
104:1278–1287. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Yu W, Park SK, Jia L, Tiwary R, Scott WW,
Li J, Wang P, Simmons-Menchaca M, Sanders BG and Kline K:
RRR-gamma-tocopherol induces human breast cancer cells to undergo
apoptosis via death receptor 5 (DR5)-mediated apoptotic signaling.
Cancer Lett. 259:165–176. 2008. View Article : Google Scholar
|
|
37
|
Prasad S, Kaur J, Roy P, Kalra N and
Shukla Y: Theaflavins induce G2/M arrest by modulating expression
of p21waf1/cip1, cdc25C and cyclin B in human prostate carcinoma
PC-3 cells. Life Sci. 81:1323–1331. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Kuo YC, Kuo PL, Hsu YL, Cho CY and Lin CC:
Ellipticine induces apoptosis through p53-dependent pathway in
human hepatocellular carcinoma HepG2 cells. Life Sci. 78:2550–2557.
2006. View Article : Google Scholar
|
|
39
|
Pucci B, Kasten M and Giordano A: Cell
cycle and apoptosis. Neoplasia. 2:291–299. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Green JA, Berns EM, Coens C, van Luijk I,
Thompson-Hehir J, van Diest P, Verheijen RH, van de Vijver M, van
Dam P, Kenter GG, et al; EORTC Gynaecological Cancer Group.
Alterations in the p53 pathway and prognosis in advanced ovarian
cancer: A multi-factorial analysis of the EORTC Gynaecological
Cancer group (study 55865). Eur J Cancer. 42:2539–2548. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Brown R, Clugston C, Burns P, Edlin A,
Vasey P, Vojtĕsek B and Kaye SB: Increased accumulation of p53
protein in cisplatin-resistant ovarian cell lines. Int J Cancer.
55:678–684. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Lahiry L, Saha B, Chakraborty J,
Bhattacharyya S, Chattopadhyay S, Banerjee S, Choudhuri T, Mandal
D, Bhattacharyya A, Sa G, et al: Contribution of p53-mediated Bax
transactivation in theaflavin-induced mammary epithelial carcinoma
cell apoptosis. Apoptosis. 13:771–781. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Kalra N, Seth K, Prasad S, Singh M, Pant
AB and Shukla Y: Theaflavins induced apoptosis of LNCaP cells is
mediated through induction of p53, down-regulation of NF-kappa B
and mitogen-activated protein kinases pathways. Life Sci.
80:2137–2146. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Innocente SA, Abrahamson JL, Cogswell JP
and Lee JM: p53 regulates a G2 checkpoint through cyclin B1. Proc
Natl Acad Sci USA. 96:2147–2152. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Mabuchi S, Kuroda H, Takahashi R and
Sasano T: The PI3K/ AKT/mTOR pathway as a therapeutic target in
ovarian cancer. Gynecol Oncol. 137:173–179. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Kim CW, Lu JN, Go SI, Jung JH, Yi SM,
Jeong JH, Hah YS, Han MS, Park JW, Lee WS, et al: p53 restoration
can overcome cisplatin resistance through inhibition of Akt as well
as induction of Bax. Int J Oncol. 43:1495–1502. 2013.PubMed/NCBI
|
